AstraZeneca PLC/ GB0009895292 /
3/29/2023 12:00:00 AM | Chg. +5.50 | Volume | Bid5:29:40 PM | Ask5:29:40 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,431.50SEK | +0.39% | 187,971 Turnover: 266.62 mill. |
1,430.00Bid Size: - | 1,431.00Ask Size: - | 2220.04 bill.SEK | - | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.08 USD | -96.72% |
EPS Diluted: | 0.08 USD | -96.72% |
Revenues per Share: | 26.39 USD | 30.07% |
Book Value per Share: | 27.71 USD | 132.45% |
Cash Flow per Share: | 4.21 USD | 14.97% |
Dividend per Share: | 2.80 USD | 0.00% |
Total | in mill. | |
Revenues: | 37,417.00 USD | 40.58% |
Net Income: | 112.00 USD | -96.50% |
Operating Cash Flow: | 5,963.00 USD | - |
Cash and Cash Equivalents: | 6,329.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 1,716.94 | 1,472.63 |
P/S Ratio: | 5.21 | 4.46 |
P/BV ratio: | 4.96 | 4.25 |
P/CF Ratio: | 32.66 | 28.02 |
PEG: | -17.75 | -15.23 |
Earnings Yield: | 0.06% | 0.07% |
Dividend Yield: | 2.04% | 2.38% |
Market Capitalization | ||
Market Capitalization: | 2220.04 bill. SEK | 1510.96 bill. SEK |
Free Float Market Cap.: | 1633.95 bill. SEK | 1173.11 bill. SEK |
Market Cap. / Employee: | 24.46 mill. SEK | 18.18 mill. SEK |
Shares Outstanding: | 1.55 bill. |
Profitability
Gross Profit Margin: | 72.54% |
EBIT Margin: | 2.82% |
Net Profit Margin: | 0.30% |
Return on Equity: | 0.29% |
Return on Assets: | 0.11% |
Financial Strength
Liquidity I / Cash Ratio: | 28.01% |
Liquidity II / Quick Ratio: | 28.01% |
Liquidity III / Current Ratio: | 116.15% |
Debt / Equity Ratio: | 168.19% |
Dynam. Debt / Equity Ratio: | 1,108.10% |
Efficiency
Employees: | 83,100 |
Personal Expenses / Employee: | 123,646.21 USD |
Revenues / Employee: | 450,264.74 USD |
Net Income / Employee: | 1,347.77 USD |
Total Assets / Employee: | 1,267,906.14 USD |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | - |
Currency: | USD |